Hanson & Doremus Investment Management Novartis Ag Transaction History
Hanson & Doremus Investment Management
- $637 Million
- Q4 2024
A detailed history of Hanson & Doremus Investment Management transactions in Novartis Ag stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 625 shares of NVS stock, worth $65,893. This represents 0.01% of its overall portfolio holdings.
Number of Shares
625
Previous 625
-0.0%
Holding current value
$65,893
Previous $71,000
15.49%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding NVS
# of Institutions
1,468Shares Held
134MCall Options Held
1.4MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.29 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.16 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$863 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$724 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$588 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $227B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...